Circulating SERPINA3 improves prognostic stratification in patients with a de novo or worsened heart failure

Circulating SERPINA3 improves prognostic stratification in patients with a de novo or worsened heart failure

Abstract Aims We investigated the prognostic relevance of serpin peptidase inhibitor, clade A member 3 (SERPINA3) in patients admitted with a de novo or worsened heart failure (HF). Methods and results In the first stage, 83 HF‐related left ventricular (LV) transcripts were examined in patients with...

Full description

Bibliographic Details
Main Authors: Leen Delrue, Marc Vanderheyden, Monika Beles, Pasquale Paolisso, Giuseppe Di Gioia, Riet Dierckx, Sofie Verstreken, Marc Goethals, Ward Heggermont, Jozef Bartunek
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:ESC Heart Failure
Subjects:
Heart failure
Prognosis
Biomarkers
Inflammation
Cardiomyopathy
Online Access:https://doi.org/10.1002/ehf2.13659

Internet

https://doi.org/10.1002/ehf2.13659

Similar Items